标题
CSF Apo-E levels associate with cognitive decline and MRI changes
作者
关键词
Cerebrospinal fluid, Plasma, Dementia, Beta amyloid, Tau, MRI, Dementia, Neurodegeneration, Alzheimer’s disease, <em class=EmphasisTypeItalic >APOE</em>
出版物
ACTA NEUROPATHOLOGICA
Volume 127, Issue 5, Pages 621-632
出版商
Springer Nature
发表日期
2014-01-02
DOI
10.1007/s00401-013-1236-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Lack of reliable evidence for a distinctive ε4−related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study
- (2013) Jonathan K. Foster et al. BRAIN
- Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
- (2013) Jon B. Toledo et al. BRAIN
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
- (2013) Katherine D LaClair et al. Molecular Neurodegeneration
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel
- (2013) Sungeun Kim et al. PLoS One
- Response to Comments on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) G. E. Landreth et al. SCIENCE
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) N. F. Fitz et al. SCIENCE
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) I. Tesseur et al. SCIENCE
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) K. Veeraraghavalu et al. SCIENCE
- Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"
- (2013) A. R. Price et al. SCIENCE
- Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
- (2013) Jon B Toledo et al. Alzheimers Research & Therapy
- Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
- (2012) Michal J. Figurski et al. Alzheimers & Dementia
- Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice
- (2012) Min Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
- (2012) Holly D. Soares ARCHIVES OF NEUROLOGY
- Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
- (2012) James D. Doecke ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
- (2012) Carlos Cruchaga et al. HUMAN MOLECULAR GENETICS
- Within-subject template estimation for unbiased longitudinal image analysis
- (2012) Martin Reuter et al. NEUROIMAGE
- Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
- (2012) W. T. Hu et al. NEUROLOGY
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
- (2011) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
- (2011) Michael W. Weiner et al. Alzheimers & Dementia
- Age-Dependent Changes in the Cerebrospinal Fluid Proteome by Slow Off-Rate Modified Aptamer Array
- (2011) Geoffrey S. Baird et al. AMERICAN JOURNAL OF PATHOLOGY
- Cholesterol Level and Statin Use in Alzheimer Disease
- (2011) Nina E. Shepardson ARCHIVES OF NEUROLOGY
- Cholesterol Level and Statin Use in Alzheimer Disease
- (2011) Nina E. Shepardson ARCHIVES OF NEUROLOGY
- Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
- (2011) V. B. Gupta et al. NEUROLOGY
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
- (2010) James J. Donkin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Highly accurate inverse consistent registration: A robust approach
- (2010) Martin Reuter et al. NEUROIMAGE
- Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease
- (2010) D. A. Wolk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease
- (2010) Yadong Huang TRENDS IN MOLECULAR MEDICINE
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Liver X receptor activation restores memory in aged AD mice without reducing amyloid
- (2009) Tim Vanmierlo et al. NEUROBIOLOGY OF AGING
- The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase
- (2009) Taher Darreh-Shori et al. NEUROBIOLOGY OF AGING
- Fibrillar amyloid- burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- (2009) E. M. Reiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
- (2008) Clifford R. Jack et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study
- (2008) M D M Haag et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
- (2008) D. R. Riddell et al. JOURNAL OF NEUROSCIENCE
- APOE 4 allele predicts faster cognitive decline in mild Alzheimer disease
- (2008) S. Cosentino et al. NEUROLOGY
- ApoE Promotes the Proteolytic Degradation of Aβ
- (2008) Qingguang Jiang et al. NEURON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search